Associations of 25-Hydroxyvitamin D Status and Supplementation with Adverse Outcomes in Geriatric Rehabilitation Inpatients: RESORT - 18/01/24

Doi : 10.1007/s12603-023-2021-y 
L. Guan 1, 4, 5, E.M. Reijnierse 1, 2, Andrea B. Maier 1, 3, 4, 5, 6
1 Department of Medicine and Aged Care, @AgeMelbourne, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia 
2 Department of Rehabilitation Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, The Netherlands 
3 Faculty of Behavioural and Movement Sciences, Department of Human Movement Sciences, @AgeAmsterdam, Vrije Universiteit, Amsterdam Movement Sciences, Amsterdam, the Netherlands 
4 Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 
5 Centre for Healthy Longevity, @AgeSingapore, National University Health System, Singapore, Singapore 
6 Department of Medicine and Aged Care, @Age, Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences, VU University Amsterdam, Amsterdam Movement Sciences, van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands 

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Objectives

Geriatric rehabilitation inpatients are at a higher risk of 25-hydroxyvitamin D (25(OH)D) deficiency due to poor nutrition and low sunlight exposure. This study aimed to evaluate the prevalence of 25-hydroxyvitamin (25(OH)D) deficiency and supplementation and to investigate their association with adverse health outcomes in geriatric rehabilitation inpatients.

Design

Prospective, observational and longitudinal study.

Setting and Participants

Geriatric rehabilitation inpatients admitted to geriatric rehabilitation wards at the Royal Melbourne Hospital (Melbourne, Australia) from 16th, October 2017 and discharged until 18th, March 2020 in the REStORing health of acutely unwell adulTs (RESORT) study were included.

Methods

25(OH)D levels measured close to rehabilitation admission were classified as sufficiency (>54 nmol/L), insufficiency (26–54 nmol/L), or deficiency (<26 nmol/L). The usage of vitamin D supplementation was extracted from medication records. Outcomes included incidence of institutionalization at three-month post-discharge, in-hospital mortality and post-discharge mortality.

Results

The median age of 1328 geriatric rehabilitation inpatients was 83.9 years (IQR: 78.1–88.7, 58.6% female). 25(OH)D deficiency and insufficiency were present in 8.1% and 26.4% of inpatients, respectively; 74.2% used vitamin D supplementation. 25(OH)D deficiency was associated with higher odds of institutionalization (odds ratio (OR): 1.88, 95% confidence interval (CI): 1.14–3.11), in-hospital mortality (OR: 3.30, 95% CI: 1.54–7.07) and higher risks of one-year mortality (hazard ratio (HR): 1.77, 95% CI: 1.17–2.69) compared to 25(OH)D sufficiency but not with three-month mortality. 25(OH)D insufficiency was not associated with outcomes. Patients who did not use supplementation and had 25(OH)D insufficiency or deficiency had significantly higher in-hospital mortality compared to those who used supplementation.

Conclusions

Among geriatric rehabilitation inpatients, 25(OH) D deficiency was associated with institutionalization, in-hospital mortality and one-year mortality. Attention to monitor the vitamin D status is of upmost importance during hospitalization.

Le texte complet de cet article est disponible en PDF.

Key words : Ageing, vitamin D deficiency, institutionalization, mortality, rehabilitation


Plan


© 2023  © 2023 SERDI Publisher.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 27 - N° 12

P. 1206-1211 - décembre 2023 Retour au numéro
Article précédent Article précédent
  • Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial
  • Sangeetha Shyam, J.F. García-Gavilán, I. Paz-Graniel, J.J. Gaforio, M.Á. Martínez-González, D. Corella, J.A. Martínez, Á.M. Alonso-Gómez, J. Wärnberg, J. Vioque, D. Romaguera, J. López-Miranda, R. Estruch, F.J. Tinahones, J. Lapetra, J.L. Serra-Majem, A. Bueno-Cavanillas, J.A. Tur, V. Martín Sánchez, X. Pintó, P. Matía-Martín, J. Vidal, M. del Mar Alcarria, L. Daimiel, E. Ros, F. Fernandez-Aranda, S.K. Nishi, Ó. García-Regata, R. Perez Araluce, E.M. Asensio, O. Castañer, A. Garcia-Rios, A. Oncina-Cánovas, C. Bouzas, M.A. Zulet, E. Rayó, R. Casas, S. Martin-Pelaez, L. Tojal-Sierra, M.R. Bernal-López, S. Carlos, J.V. Sorlí, A. Goday, P.J. Peña-Orihuela, A. Pastor-Morel, S. Eguaras, M.D. Zomeño, M. Delgado-Rodríguez, N. Babio, M. Fitó, Jordi Salas-Salvadó
| Article suivant Article suivant
  • Screening of Fracture Risk and Osteoporosis Among Older Long-term Care Residents: A Prospective Study
  • S.-H. Fu, C.-Y. Lai, C.-Y. Wang, C.-C. Hung, J.-D. Ye, H.-K. Yen, C.-H. Wu, L.-J.E. Ku, T. Yu, R.-S. Yang, F.-Y. Hsiao, Chung-Yi Li

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.